Steven R Alberts Selected Research

Exanthema (Rash)

1/2009	Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.
6/2005	A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven R Alberts Research Topics

Disease

79	Neoplasms (Cancer) 01/2022 - 01/2002
42	Colonic Neoplasms (Colon Cancer) 11/2023 - 05/2004
29	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2004
14	Adenocarcinoma 01/2022 - 01/2002
13	Neoplasm Metastasis (Metastasis) 01/2017 - 10/2005
12	Carcinoma (Carcinomatosis) 10/2023 - 01/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 06/2005
8	Vomiting 07/2023 - 01/2004
7	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2007
6	Nausea 07/2023 - 01/2004
6	Diarrhea 07/2023 - 01/2004
6	Klatskin Tumor 09/2012 - 05/2004
5	Neutropenia 07/2023 - 01/2002
5	Cholangiocarcinoma 01/2022 - 05/2007
4	Hypertension (High Blood Pressure) 07/2023 - 04/2007
4	Stomach Neoplasms (Stomach Cancer) 12/2021 - 03/2010
4	Disease Progression 01/2020 - 05/2004
4	Fatigue 01/2020 - 04/2005
3	Hemorrhage 07/2023 - 06/2006
3	Febrile Neutropenia 07/2023 - 01/2004
3	Dehydration (Water Stress) 07/2023 - 01/2004
3	Anemia 01/2021 - 04/2005
2	Lymphatic Metastasis 10/2021 - 05/2006
2	Sclerosing Cholangitis 09/2012 - 10/2007
2	Esophageal Neoplasms (Esophageal Cancer) 12/2010 - 10/2007
2	Exanthema (Rash) 01/2009 - 06/2005
2	Breast Neoplasms (Breast Cancer) 07/2003 - 01/2002
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Stomatitis 01/2021
1	Leukopenia 01/2021
1	Inflammation (Inflammations) 01/2020
1	Turcot syndrome 01/2020
1	Microsatellite Instability 01/2020

Drug/Important Bio-Agent (IBA)

33	Fluorouracil (Carac)FDA LinkGeneric 07/2023 - 03/2002
27	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 01/2004
21	Leucovorin (Folinic Acid)FDA Link 07/2023 - 01/2004
17	Gemcitabine FDA Link 01/2022 - 01/2003
16	Cetuximab (Erbitux)FDA Link 01/2021 - 09/2005
12	Irinotecan (Camptosar)FDA LinkGeneric 10/2023 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2003
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
7	Sodium Glutamate (Accent)IBA 01/2023 - 01/2010
6	Bevacizumab (Avastin)FDA Link 07/2023 - 09/2006
6	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 07/2003
6	Carboplatin (JM8)FDA LinkGeneric 12/2010 - 08/2002
5	Capecitabine (Xeloda)FDA Link 01/2021 - 05/2004
4	Codon (Codons)IBA 04/2017 - 10/2013
4	Pemetrexed (MTA)FDA Link 12/2010 - 06/2005
4	Bortezomib (Velcade)FDA Link 05/2008 - 05/2005
3	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2002
3	Antineoplastic Agents (Antineoplastics)IBA 12/2016 - 01/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2008 - 02/2007
3	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2007 - 05/2005
3	Proteasome InhibitorsIBA 02/2007 - 05/2005
2	trifluridine tipiracil drug combinationIBA 10/2023 - 01/2020
2	Dihydrotachysterol (AT 10)IBA 07/2023 - 04/2007
2	Drug CombinationsIBA 07/2023 - 01/2004
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2016
2	Panitumumab (Vectibix)FDA Link 01/2022 - 01/2019
2	Epirubicin (Ellence)FDA LinkGeneric 12/2021 - 11/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2017 - 06/2014
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 06/2014
2	A-Form DNA (A-DNA)IBA 08/2013 - 01/2007
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 10/2007 - 08/2007
2	Folic Acid AntagonistsIBA 07/2007 - 01/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2007 - 01/2002
2	KW 2189IBA 01/2007 - 06/2002
2	Epoetin Alfa (Epogen)FDA Link 03/2006 - 04/2005
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	AdiponectinIBA 10/2021
1	hydroxide ionIBA 10/2021
1	25-hydroxyvitamin DIBA 10/2021
1	Vitamin D FDA LinkGeneric 10/2021
1	C-Reactive ProteinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	LigandsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	Mismatch Repair Endonuclease PMS2IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020

Therapy/Procedure

47	Therapeutics 07/2023 - 01/2002
33	Drug Therapy (Chemotherapy) 11/2023 - 01/2002
19	Adjuvant Chemotherapy 01/2023 - 01/2009
7	Neoadjuvant Therapy 01/2021 - 05/2004
7	Liver Transplantation 01/2020 - 05/2004
5	Radiotherapy 11/2017 - 06/2007
4	Immunotherapy 01/2020 - 09/2009
3	Folfox protocol 07/2023 - 01/2004
3	Transplantation 09/2012 - 10/2004
2	Chemoradiotherapy 01/2022 - 11/2017
2	Cholecystectomy 09/2012 - 12/2006
2	Chemoprevention 04/2012 - 07/2006
2	Cryosurgery 03/2012 - 02/2010
1	Induction Chemotherapy 01/2021
1	Treatment Delay 01/2021
1	Salvage Therapy 01/2020